FindTrial
Sign In

computerized tomography (CT) scan

OTHER2 trials

Sponsors

Centre Hospitalier Universitaire, Amiens, Kelly Fitzgerald, MD

Conditions

Bone Metastases of a Malignant TumorBone, Metastatic CancerClear Cell Renal CancerClear Cell Renal CarcinomaClear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma MetastaticCochlear Hearing Loss

Phase 2

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
RecruitingNCT07043608
Kelly Fitzgerald, MDBone Metastases of a Malignant Tumor, Bone, Metastatic Cancer, Clear Cell Renal Cancer +7
Start: 2026-06-10End: 2030-04-30Target: 20Updated: 2026-07-27

Unknown Phase

Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation
CompletedNCT04048239
Centre Hospitalier Universitaire, AmiensCochlear Hearing Loss, Implant
Start: 2019-10-01End: 2023-09-12Updated: 2025-09-19

Related Papers

ZAMBONI: A phase II study of zanzalintinib for metastatic clear cell renal cell carcinoma with bone metastases previously treated with immune checkpoint inhibitors.
Journal of Clinical Oncology2026-05-28